Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis' blockbuster heart-failure ...

CHANGSHU (China): Nexteer Automotive has opened its new facility in Changshu in a strategic expansion of its advanced steering systems manufacturing and testing capabilities. This expansion positions ...

Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal ...

Tired of sitting in traffic dreaming of a quick escape from Shanghai? Well, dream no more! Starting today (December 31), you can fly to Changshu, Jiangsu Province, in just 20 minutes. Yes, 20 minutes ...

Novartis AG said a new experimental medicine improved motor function in children with a form of spinal muscular atrophy, the devastating disorder targeted by its gene therapy Zolgensma, in an ...

The U.S. Court of Appeals for the Second Circuit partially upheld and partially vacated a district court's ruling in a False Claims Act case against Novartis Pharmaceuticals. The lawsuit ...

The most common adverse events were upper respiratory tract infection, pyrexia and vomiting. Novartis plans to share results with regulatory agencies in 2025, including the US Food and Drug ...

Filing the intimation received from Registrar and Share Transfer Agent on the loss of Share Certificate dated August 03, 2024.

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...